Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 6345656, 8 pages
http://dx.doi.org/10.1155/2016/6345656
Research Article

Osteopontin Promotes Expression of Matrix Metalloproteinase 13 through NF-κB Signaling in Osteoarthritis

1Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha 410078, China
2Department of Bone and Joint, The Second Clinical Medical College (Shenzhen People’s Hospital), Jinan University, Shenzhen 518020, China
3Department of Orthopaedics, Second People’s Hospital of Jingmen, Jingmen 448000, China
4Department of Joint Surgery, Changsha Central Hospital, Changsha 410000, China

Received 28 June 2016; Accepted 7 August 2016

Academic Editor: Yong Zhao

Copyright © 2016 Yusheng Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. R. Poole, “An introduction to the pathophysiology of osteoarthritis,” Frontiers in Bioscience, vol. 4, pp. D662–D670, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. L. L. Laslett, S. J. Quinn, T. M. Winzenberg, K. Sanderson, F. Cicuttini, and G. Jones, “A prospective study of the impact of musculoskeletal pain and radiographic osteoarthritis on health related quality of life in community dwelling older people,” BMC Musculoskeletal Disorders, vol. 13, article 168, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Cheng, S. Gao, and G. Lei, “Association of osteopontin with osteoarthritis,” Rheumatology International, vol. 34, pp. 1627–1631, 2014. View at Google Scholar
  4. A. D. Woolf and B. Pfleger, “Burden of major musculoskeletal conditions,” Bulletin of the World Health Organization, vol. 81, no. 9, pp. 646–656, 2003. View at Google Scholar · View at Scopus
  5. M. A. Lampe, R. Patarca, M. V. Iregui, and H. Cantor, “Polyclonal B cell activation by the Eta-1 cytokine and the development of systemic autoimmune disease,” Journal of Immunology, vol. 147, no. 9, pp. 2902–2906, 1991. View at Google Scholar · View at Scopus
  6. A. W. O'Regan, G. J. Nau, G. L. Chupp, and J. S. Berman, “Osteopontin (Eta-1) in cell-mediated immunity: teaching an old dog new tricks,” Immunology Today, vol. 21, no. 10, pp. 475–478, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. E. M. Gravallese, “Osteopontin: a bridge between bone and the immune system,” The Journal of Clinical Investigation, vol. 112, no. 2, pp. 147–149, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. F.-J. Zhang, S.-G. Gao, L. Cheng et al., “The effect of hyaluronic acid on osteopontin and CD44 mRNA of fibroblast-like synoviocytes in patients with osteoarthritis of the knee,” Rheumatology International, vol. 33, no. 1, pp. 79–83, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. D. T. Denhardt and M. Noda, “Osteopontin expression and function: role in bone remodeling,” Journal of Cellular Biochemistry, vol. 30-31, no. 31, pp. 92–102, 1998. View at Google Scholar · View at Scopus
  10. D. T. Denhardt and X. Guo, “Osteopontin: a protein with diverse functions,” FASEB Journal, vol. 7, no. 15, pp. 1475–1482, 1993. View at Google Scholar · View at Scopus
  11. J. Sodek, J. Chen, T. Nagata et al., “Regulation of osteopontin expression in osteoblasts,” Annals of the New York Academy of Sciences, vol. 760, pp. 223–241, 1995. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Standal, M. Borset, and A. Sundan, “Role of osteopontin in adhesion, migration, cell survival and bone remodeling,” Experimental Oncology, vol. 26, no. 3, pp. 179–184, 2004. View at Google Scholar · View at Scopus
  13. M. A. Chellaiah and K. A. Hruska, “The integrin αvβ3 and CD44 regulate the actions of osteopontin on osteoclast motility,” Calcified Tissue International, vol. 72, no. 3, pp. 197–205, 2003. View at Publisher · View at Google Scholar
  14. O. Pullig, G. Weseloh, S. Gauer, and B. Swoboda, “Osteopontin is expressed by adult human osteoarthritic chondrocytes: protein and mRNA analysis of normal and osteoarthritic cartilage,” Matrix Biology, vol. 19, no. 3, pp. 245–255, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. S. G. Gao, K. H. Li, K. B. Zeng, M. Tu, M. Xu, and G. H. Lei, “Elevated osteopontin level of synovial fluid and articular cartilage is associated with disease severity in knee osteoarthritis patients,” Osteoarthritis and Cartilage, vol. 18, no. 1, pp. 82–87, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Honsawek, A. Tanavalee, M. Sakdinakiattikoon, M. Chayanupatkul, and P. Yuktanandana, “Correlation of plasma and synovial fluid osteopontin with disease severity in knee osteoarthritis,” Clinical Biochemistry, vol. 42, no. 9, pp. 808–812, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Xu, L. Zhang, L. Zhao et al., “Phosphorylation of osteopontin in osteoarthritis degenerative cartilage and its effect on matrix metalloprotease 13,” Rheumatology International, vol. 33, no. 5, pp. 1313–1319, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. P. J. Roughley, “Articular cartilage and changes in arthritis: noncollagenous proteins and proteoglycans in the extracellular matrix of cartilage,” Arthritis Research, vol. 3, no. 6, pp. 342–347, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Eyre, “Collagen of articular cartilage,” Arthritis Research, vol. 4, no. 1, pp. 30–35, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Yatabe, S. Mochizuki, M. Takizawa et al., “Hyaluronan inhibits expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic chondrocytes,” Annals of the Rheumatic Diseases, vol. 68, no. 6, pp. 1051–1058, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Verma and K. Dalal, “ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis,” Journal of Cellular Biochemistry, vol. 112, no. 12, pp. 3507–3514, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Aigner, K. Fundel, J. Saas et al., “Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis,” Arthritis and Rheumatism, vol. 54, no. 11, pp. 3533–3544, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. L. C. Tetlow, D. J. Adlam, and D. E. Woolley, “Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes,” Arthritis and Rheumatism, vol. 44, no. 3, pp. 585–594, 2001. View at Google Scholar · View at Scopus
  24. Y. Matsui, N. Iwasaki, S. Kon et al., “Accelerated development of aging-associated and instability-induced osteoarthritis in osteopontin-deficient mice,” Arthritis and Rheumatism, vol. 60, no. 8, pp. 2362–2371, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Ren, J. Yin, M. Wu et al., “Serum amino acids profile and the beneficial effects of L-arginine or L-glutamine supplementation in dextran sulfate sodium colitis,” PLoS ONE, vol. 9, no. 2, Article ID e88335, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. W. Ren, J. Yin, J. Duan et al., “Mouse jejunum innate immune responses altered by enterotoxigenic Escherichia coli (ETEC) infection,” Microbes and Infection, vol. 16, no. 11, 2014. View at Google Scholar
  27. Z.-W. He, Y.-H. Qin, Z.-W. Wang, Y. Chen, Q. Shen, and S.-M. Dai, “HMGB1 acts in synergy with lipopolysaccharide in activating rheumatoid synovial fibroblasts via p38 MAPK and NF-κB signaling pathways,” Mediators of Inflammation, vol. 2013, Article ID 596716, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Zhang, Q. L. Zhu, P. Huang et al., “CpG ODN-induced matrix metalloproteinase-13 expression is mediated via activation of the ERK and NF-κB signalling pathways in odontoblast cells,” International Endodontic Journal, vol. 46, no. 7, pp. 666–674, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Cheng, F.-J. Zhang, J. Tian et al., “Osteopontin inhibits HIF-2α mRNA expression in osteoarthritic chondrocytes,” Experimental and Therapeutic Medicine, vol. 9, no. 6, pp. 2415–2419, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. S.-G. Gao, C. Zeng, Y. Song et al., “Effect of osteopontin on the mRNA expression of ADAMTS4 and ADAMTS5 in chondrocytes from patients with knee osteoarthritis,” Experimental and Therapeutic Medicine, vol. 9, no. 5, pp. 1979–1983, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. N. Kang, P. Chen, Y. Chen, H. Zeng, X. He, and Y. Zhu, “PRMT6 mediates CSE induced inflammation and apoptosis,” International Immunopharmacology, vol. 24, no. 1, pp. 95–101, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. W. H. Park, S. Kang, Y. Piao et al., “Ethanol extract of Bupleurum falcatum and saikosaponins inhibit neuroinflammation via inhibition of NF-κB,” Journal of Ethnopharmacology, vol. 174, pp. 37–44, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Struzik, L. Szulc-Dabrowska, A. Winnicka, and M. Niemiałtowski, “Strategies of NF-κB signaling modulation by ectromelia virus in BALB/3T3 murine fibroblasts,” Microbial Pathogenesis, vol. 87, pp. 59–68, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. W.-K. Ren, J. Yin, X.-P. Zhu et al., “Glutamine on intestinal inflammation: a mechanistic perspective,” European Journal of Inflammation, vol. 11, no. 2, pp. 315–326, 2013. View at Google Scholar · View at Scopus
  35. S. G. Gao, L. Cheng, C. Zeng et al., “Usefulness of specific OA biomarkers, thrombin-cleaved osteopontin, in the posterior cruciate ligament OA rabbit model,” Osteoarthritis and Cartilage, vol. 21, no. 1, pp. 144–150, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. X. Dong, Y. Zheng, and H. Y. Liu, “The clinical significance of serum and joint fluid osteopontin, and thrombin-cleaved osteopontin levels in osteoarthritis,” Zhonghua Nei Ke Za Zhi, vol. 52, pp. 1023–1027, 2013. View at Google Scholar
  37. F.-J. Zhang, W.-B. Yu, W. Luo, S.-G. Gao, Y.-S. Li, and G.-H. Lei, “Effect of osteopontin on TIMP-1 and TIMP-2 mRNA in chondrocytes of human knee osteoarthritis in vitro,” Experimental and Therapeutic Medicine, vol. 8, no. 2, pp. 391–394, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Yang, S.-G. Gao, F.-J. Zhang, W. Luo, J.-X. Xue, and G.-H. Lei, “Effects of osteopontin on the expression of IL-6 and IL-8 inflammatory factors in human knee osteoarthritis chondrocytes,” European Review for Medical and Pharmacological Sciences, vol. 18, no. 23, pp. 3580–3586, 2014. View at Google Scholar · View at Scopus
  39. T. Min, L. Y. Sheng, C. Chao, T. Jian, G. S. Guang, and L. G. Hua, “Correlation between osteopontin and caveolin-1 in the pathogenesis and progression of osteoarthritis,” Experimental and Therapeutic Medicine, vol. 9, no. 6, pp. 2059–2064, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Ahmed and G. C. Kundu, “Osteopontin selectively regulates p70S6K/mTOR phosphorylation leading to NF-κB dependent AP-1-mediated ICAM-1 expression in breast cancer cells,” Molecular Cancer, vol. 9, article 101, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Liu, Q. Liu, Y. Wan et al., “Osteopontin promotes the progression of gastric cancer through the NF-κB pathway regulated by the MAPK and PI3K,” International Journal of Oncology, vol. 45, no. 1, pp. 282–290, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. W. Zhu, C. Jiang, J. Xu et al., “Pristane primed rat T cells enhance TLR3 expression of fibroblast-like synoviocytes via TNF-α initiated p38 MAPK and NF-κB pathways,” Clinical Immunology, vol. 156, no. 2, pp. 141–153, 2015. View at Publisher · View at Google Scholar · View at Scopus